NCT05672199 Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT05669599 Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT05669040 mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health Status UNKNOWN Phase NA
NCT05669014 A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) Status COMPLETED Phase PHASE2
NCT05651711 A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) Status COMPLETED Phase PHASE3
NCT05633355 A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT05626751 An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) Status TERMINATED Phase PHASE2
NCT05599828 A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05598281 Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants Status COMPLETED Phase PHASE1
NCT05591222 Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus Status TERMINATED Phase PHASE2
NCT05583227 Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05581992 Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05581758 A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05581303 Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05578859 A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT05577624 A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05571163 A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants Status COMPLETED Phase PHASE1
NCT05568082 A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05565560 A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3